BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 33755503)

  • 1. Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities.
    Khorsandi K; Hosseinzadeh R; Sadat Esfahani H; Keyvani-Ghamsari S; Ur Rahman S
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1299-1323. PubMed ID: 33755503
    [No Abstract]   [Full Text] [Related]  

  • 2. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-therapeutics: A revolution in infection control in post antibiotic era.
    Zaidi S; Misba L; Khan AU
    Nanomedicine; 2017 Oct; 13(7):2281-2301. PubMed ID: 28673854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalization of Inorganic Nanoparticles to Augment Antimicrobial Efficiency: A Critical Analysis.
    Khan K; Javed S
    Curr Pharm Biotechnol; 2018; 19(7):523-536. PubMed ID: 30062962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in antibacterial applications of metal nanoparticles (MNPs) and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria.
    Alavi M; Rai M
    Expert Rev Anti Infect Ther; 2019 Jun; 17(6):419-428. PubMed ID: 31046483
    [No Abstract]   [Full Text] [Related]  

  • 9. Insights in Nanoparticle-Bacterium Interactions: New Frontiers to Bypass Bacterial Resistance to Antibiotics.
    Diab R; Khameneh B; Joubert O; Duval R
    Curr Pharm Des; 2015; 21(28):4095-105. PubMed ID: 26420233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nanotechnology in combating multi-drug resistant bacteria.
    Singh R; Smitha MS; Singh SP
    J Nanosci Nanotechnol; 2014 Jul; 14(7):4745-56. PubMed ID: 24757944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.
    Pardhi DM; Şen Karaman D; Timonen J; Wu W; Zhang Q; Satija S; Mehta M; Charbe N; McCarron PA; Tambuwala MM; Bakshi HA; Negi P; Aljabali AA; Dua K; Chellappan DK; Behera A; Pathak K; Watharkar RB; Rautio J; Rosenholm JM
    Int J Pharm; 2020 Aug; 586():119531. PubMed ID: 32540348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles.
    Van Giau V; An SSA; Hulme J
    Drug Des Devel Ther; 2019; 13():327-343. PubMed ID: 30705582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-based local antimicrobial drug delivery.
    Gao W; Chen Y; Zhang Y; Zhang Q; Zhang L
    Adv Drug Deliv Rev; 2018 Mar; 127():46-57. PubMed ID: 28939377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
    Elfadil D; Elkhatib WF; El-Sayyad GS
    Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria.
    Khan AA; Manzoor KN; Sultan A; Saeed M; Rafique M; Noushad S; Talib A; Rentschler S; Deigner HP
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobiotechnological Approaches Against Multidrug Resistant Bacterial Pathogens: An Update.
    Shaikh S; Shakil S; Abuzenadah AM; Rizvi SM; Roberts PM; Mushtaq G; Kamal MA
    Curr Drug Metab; 2015; 16(5):362-70. PubMed ID: 26419545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimetallic Nanoparticles as Alternative Antimicrobial Agents: Challenges and Perspectives.
    Basavegowda N; Baek KH
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33572219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.